Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy

Diabetes Care

Volumn 29, Issue 3, 2006, Pages 498-503

  Sasso, Ferdinando C ^a   De Nicola, Luca ^a   Carbonara, Ornella ^a   Nasti, Rodolfo ^a   Minutolo, Roberto ^a   Salvatore, Teresa ^a   Conte, Giuseppe ^a   Torella, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; ALBUMINURIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 33744987368     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.03.06.dc05-1776     Document Type: Article

References (24)

1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63:225-232, 2003
2. Mitch WE: Treating diabetic nephropathy: are there only economic issues? N Engl J Med 351:1934-1936, 2004
3. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH: Progression of nephropathy in type 2 diabetic patients. Kidney Int 66:1596-1605, 2004
4. Mohanram A, Zhongxin Z, Sheninfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66:1131-1138, 2004
5. Joss N, Ferguson C, Brown C, Deighan CJ, Paterson KR, Boulton-Jones JM: Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy. Q J Med 97:219-227, 2004
6. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, the Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
7. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
8. Perez-Maraver M, Carrera Santaliestra MJ, Vinzia Uriach G, Micolo Duran T, Gomez Amaiz N, Sahun de la Vega M: Early diabetic nephropathy and cardiovascular disease in a Mediterranean population: risk factors and treatment intensity. Rev Clin Exp 5:255-259, 2004
9. Parving H-H, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001
10. Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW: Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 321:1440-1444, 2000
11. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B: Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39: 1569, 1996
12. Nosadini R, Velussi M, Brocco E, Bruseghin M, Abaterusso C, Saller A, Dalla Vestra M, Carraro A, Bortoloso E, Sambataro M, Barzon I, Frigato F, Muollo B, Chiesura-Corona M, Pacini G, Baggio B, Piarulli F, Sfriso A, Fioretto P: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 49: 476-484, 2000
13. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M, Boldorini R: Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. Am J Kidney Dis 39:713-720, 2002
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee: Guidelines for the management of arterial hypertension. J Hypertens 21:1011-1053, 2003
15. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 28:S4-S36, 2005
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL: Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 42:1206-1252, 2003
17. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, Forst DH, Fraser AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK, Klein AL, Lang RM, Pierard LA, Quinones MA, Schnittger I: American Society of Echocardiography Report: recommendations for a standardized report for adult transthoracic echocardiography. J Am Soc Echocardiogr 15:275-290, 2002
18. Diabetes Control and Complications (DCCT) Research Group: The effect of intensive treatment of diabetes on the development and progression for long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
19. UK Prospective Diabetes Study. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998
20. De Nicola L, Minutolo R, Bellizzi V, Zoccali C, Cianciaruso B, Andreucci VE; investigators of the Target Blood Pressure Levels in Chronic Kidney Disease (TABLE in CKD) Study Group: Achievement of target blood pressure levels in chronic kidney disease: a salty question ? Am J Kidney Dis 43:782-795, 2004
21. Brater DC: Diuretic therapy. N Engl J Med 339:387-395, 1998
22. Centers for Disease Control and Prevention, National Center for Health Statistics: Vital and Health Statistics, Plan and Operation of the Third National Health and Nutrition and Examination Survey, 1988-1994. Rockville, MD, U.S. Department of Health and Human Services, Public Health Service, 1994, p. 4-485 (DHHS publ. no. PHS 94-1308, series 1, no. 32)
23. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342, 2004
24. Liebl A, Mata M, Eschwège E: Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 45:S23-S8, 2002